CrossRef Hepatic Outcomes in Lean Versus Nonlean Metabolic DysfunctionAssociated Steatotic Liver Disease: PropensityMatched Cohort Study Rishi Chowdhary, Manjeet Kumar Goyal, Ashita Rukmini Vuthaluru, Megh Patel, Tanisha Sehgal, Kirti Arora, Rahul Chowdhary, Varun Mehta, Akash Batta, Omesh Goyal Hepatology Research .2026
References Deanfield, John et al., Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial, The Lancet, Published on October 22, 2025, DOI: 10.1016/S0140-6736(25)01375-3 Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity (SELECT), ClinicalTrials.gov ID NCT03574597,
Though they have been known as a skin whitening injection, the Glow Drips at UNCOVER Clinics focus on brightening your skin complexion
In addition, do not use if you have: multiple endocrine neoplasia type 2 (tumors in your glands) a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer)